Author:
Yoder Kristine E.,Rabe Anthony J.,Larue Ross C.
Publisher
Springer International Publishing
Reference107 articles.
1. Sinn, P. L., Sauter, S. L., & McCray, P. B., Jr. (2005). Gene therapy progress and prospects: Development of improved lentiviral and retroviral vectors - design, biosafety, and production. Gene Therapy, 12(14), 1089–1098. https://doi.org/10.1038/sj.gt.3302570
2. Coffin, J. M., Hughes, S. H., & Varmus, H. E. (1997). In J. M. Coffin, S. H. Hughes, & H. E. Varmus (Eds.), Retroviruses. Cold Spring Harbor Laboratory Press.
3. Kobiler, O., Drayman, N., Butin-Israeli, V., & Oppenheim, A. (2012). Virus strategies for passing the nuclear envelope barrier. Nucleus, 3(6), 526–539. https://doi.org/10.4161/nucl.21979
4. Matreyek, K. A., & Engelman, A. (2013). Viral and cellular requirements for the nuclear entry of retroviral preintegration nucleoprotein complexes. Viruses, 5(10), 2483–2511. https://doi.org/10.3390/v5102483
5. Shun, M. C., Raghavendra, N. K., Vandegraaff, N., Daigle, J. E., Hughes, S., Kellam, P., et al. (2007). LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration. Genes & Development, 21(14), 1767–1778.